ARCHIVES

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

Intercultural Cancer Council Endorses New NCI Office

July 5, 1996

With Fighter Planes Overhead, ODAC Kept Deliberating.

September 21, 2001

In Brief: Cancer Bill Nearly Became Law Without Nixon’s Signature as Impeachment Obsesses White House

August 2, 1974

Overdiagnosis Can Result In Harm To Patients, Experts Say.

November 3, 2006

Henschke Responds To Articles On I-ELCAP.

January 12, 2007

NCI Staff Working Group Leans Toward Starting COP With Community Hospitals As Lead Funding Agencies

January 1, 1982